Machine learning-based predictive model for immune checkpoint inhibitors response in gastrointestinal cancers

IntroductionGastrointestinal (GI) cancers present significant clinical challenges characterized by dismal survival outcomes and suboptimal prognoses. Currently, only partial indicators are available to predict the response of immunotherapy. A critical gap remains in the development of models capable...

Full description

Bibliographic Details
Published in:	Frontiers in Medicine
Main Authors:	Yufan Lv, Qingbin Wang, Huiting Xu, Jing Dai, Yongchang Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	predictive model immune checkpoint inhibitors treatment gastrointestinal malignancies machine learning
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1631011/full

Similar Items

Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
by: Maryam Noori, et al.
Published: (2024-01-01)

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
by: Mei-Xi Lin, et al.
Published: (2024-02-01)

Immune checkpoint inhibitors and acute kidney injury
by: Ping Zhou, et al.
Published: (2024-02-01)

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
by: Matteo Perrino, et al.
Published: (2023-01-01)

Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
by: Min Kyu Kim, et al.
Published: (2024-11-01)

Editorial: The role of immune checkpoints in gastrointestinal diseases
by: Xiaofei Shen, et al.
Published: (2023-07-01)

Patterns of hormonal changes in hypophysitis by immune checkpoint inhibitor
by: Hyunji Sang, et al.
Published: (2024-09-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
by: Ping Zhou, et al.
Published: (2024-12-01)

Immune Checkpoint Inhibitors and Liver Transplantation: Case Report and Review of the Literature
by: Iva Skocilic, et al.
Published: (2025-04-01)

Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
by: Giulio Metro, et al.
Published: (2021-09-01)

Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors
by: Shuo Xu, et al.
Published: (2025-08-01)

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer
by: Yifan Wang, et al.
Published: (2025-05-01)

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
by: Chie Kudo-Saito, et al.
Published: (2022-09-01)

Prognostic and predictive factors in advanced upper gastrointestinal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis of the current evidence
by: Puxiu Wang, et al.
Published: (2024-10-01)

Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms
by: Mihailo Miljanic, et al.
Published: (2020-02-01)

Advances in radiotherapy enhancing the efficacy of immune checkpoint inhibitors in malignant
by: Yao Liao, et al.
Published: (2025-07-01)

Research Progress of Immune Checkpoint Inhibitors  in Malignant Pleural Mesothelioma
by: Yaru HUANG, et al.
Published: (2021-06-01)

DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
by: Junya Yan, et al.
Published: (2024-03-01)

Immune checkpoint inhibitor-induced anti-Hu antibody-associated gastrointestinal pseudo-obstruction: a case report and literature review
by: Guang-Qing Shi, et al.
Published: (2025-04-01)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
by: Florian Huemer, et al.
Published: (2021-01-01)

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors
by: AN Tianqi, TIAN Jianhui, ZHOU Yiyang, LUO Bin, QUE Zujun, LIU Yao, YU Pan, ZHAO Ruihua, YANG Yun
Published: (2025-03-01)

Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
by: Li Gong, et al.
Published: (2023-06-01)

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
by: Wenxian Wang, et al.
Published: (2022-12-01)

A case of Stewart-Treves syndrome during the treatment with immune checkpoint inhibitor for occult malignant melanoma
by: Hanae Fujita, MD, et al.
Published: (2025-10-01)

Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
by: Lilong Zhang, et al.
Published: (2023-07-01)

Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management
by: Tzu-Fei Wang, et al.
Published: (2023-03-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
by: Fen Xiao, et al.
Published: (2024-08-01)

Editorial: New immunotherapy strategies and related therapeutic targets for gastrointestinal malignancies
by: Ganesan Ramamoorthi
Published: (2024-03-01)

Immune checkpoint inhibitor-associated polyneuropathy in malignant pleural mesothelioma: A case report
by: Mehdi Kashani, et al.
Published: (2025-09-01)

Increasing cure rates of solid tumors by immune checkpoint inhibitors
by: Weijie Ma, et al.
Published: (2023-01-01)

Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)

The impact of antibiotic use in gastrointestinal tumors treated with immune checkpoint inhibitors: systematic review and meta-analysis
by: Faizah M. Alotaibi, et al.
Published: (2024-06-01)

Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01)

Tumor mutation load better predicts the prognosis of patients treated with immune checkpoint inhibitors in upper gastrointestinal cancers: A systematic review and meta‐analysis
by: Chenghao Ma, et al.
Published: (2024-02-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

Hepatobiliary complications of immune checkpoint inhibitors in cancer
by: Donna Zhuang, et al.
Published: (2024-07-01)